More recently, tumor-derived IL-1β was implicated in cross-talk between prostate cancer cells and adipocytes, leading to reduced sensitivity to docetaxel via lipolysis-dependent mechanisms [64]. This evidence concerns the gene IL1B and prostate cancer.